KARO
Karo Pharma AB
European company
Healthcare
Drug Manufacturers - Specialty & Generic
/
NAV Price
-
Last Traded
-
Chg
-
-
XSTO
-
Updated: -
Times are shown in GMT+1, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
This stock can be held in:
/
Company Profile
Karo Pharma AB is a healthcare corporation. It is primarily engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are BabySlide, Ibux, Paracet, Plantur 39, Vagisan, Triolif, Dosett, Allevo, Mabs compression, and Swereco. The projects of the companies are RORgamma; Multiple sclerosis and cancer; and T268A common cold spray. It operates in the segment of research and development for drug discovery. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.Karo Pharma AB is a Sweden based healthcare corporation. It is primarily engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector.
OMX:KARO
SE0007464888
SEK
Loading Comparison
Latest KARO News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News